Global Tissue Banking Market Forecast up to 2024 - Market is Estimated to Witness a CAGR of 11.2% - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Mar 20, 2019--The “Global Tissue Banking Market Forecast up to 2024” report has been added to ResearchAndMarkets.com’s offering.
The global tissue banking market is estimated to witness a CAGR of 11.2% during the forecast period 2018-2024
The conservation and banking of tissues subsequent to donor harvest is an extended medicinal area that has until lately witnessed progress. Nevertheless, in a similar way we bank stem cells, embryos and other tissues at present are likely to govern the biological time for complete tissues through approaches identical to vitrification and controlled hypothermia.
A constant growth of tissues and organs scarcity has led to early deaths with consequences in enormous outlays to society. The capacity to bank tissues has an instantaneous effect on transplant medicine, surgical treatment of cancer, combat trauma, and industrial accidents.
The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the tissue banking market, followed by Europe, Asia Pacific, and Rest of the World. More than 44.0% of the market is occupied by North America, with the US being the major contributor to the market growth.
Based on types, the market is segmented into equipment and consumables. Equipment holds a dominant share in the market and is also the fastest growing segment.
Based on application areas, the market is segmented into clinical application and research & development. The market is dominated by research & development.
Tissue Type Analysis:
Based on tissue banking areas, the market is segmented into cardiovascular tissue, lung tissue, kidney tissue, corneal tissue, and other tissues. The corneal tissue segment is dominant among others in the market.
The tissue banking market is facing intense competition due to the presence of many players in the market. However, the majority of the market share is occupied by Thermo Fisher Scientific, Danaher Corporation, Custom Biogenic Solution, Tecan Group, and Brooks Automation, Inc.
To maintain their leadership, the major players are collaborating with small players who have advanced technology. For instance, in March 2014, Brooks Automation collaborated with BioCision for the development of automated temperature-controlled technology for biobanking and sample handling. This association helped in filling the gap amongst sample handling and automation process.
Key Topics Covered:
1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market (TAM)
1.3 Trends of the Market
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition
3.2 Segmented Addressable Market (SAM)
3.3 Industry Trends
3.4 Related Markets
3.4.1 Wound Biologics
188.8.131.52 Trends in Wound Biologics Market
3.4.2 Stem Cell Banking
184.108.40.206 Trends in Stem Cell Banking Market
4 Market Outlook
4.2 Market Segmentation
4.3 Porter 5 (Five) Forces
5 Market Characteristics
5.1 Market Dynamics
220.127.116.11 Increasing demand for regenerative medicine
18.104.22.168 Advancements in Tissue Banking Technologies
22.214.171.124 Stringent regulatory requirement
126.96.36.199 Ethical Issues
188.8.131.52 Market opportunities in Asia Pacific
184.108.40.206 Mergers and acquisitions
5.1.4 DRO - Impact Analysis
6 Types: Market Size and Analysis
6.2 Tissue Banking Equipment
6.3 Accessories and Consumables
7 Application: Market Size and Analysis
7.2 Clinical Application
7.3 Research and Development
8 Types: Market Size and Analysis
8.2 Cardiovascular Tissue
8.3 Corneal Tissue
8.4 Lungs Tissue
8.5 Kidney Tissue
8.6 Others Tissue
9 Regions: Market Size and Analysis
9.2 North America
9.4 Asia Pacific
9.5 Rest of the World
10 Competitive Landscape
11 Vendors Profile
11.1 Thermo Fisher Scientific, INC.
11.1.2 Business Units
11.1.3 Geographic Presence
11.1.4 Business focus
11.1.5 SWOT analysis
11.1.6 Business Strategy
11.2 Danaher Corporation
11.3 Custom Biogenic Systems INC
11.4 Brooks Automation, INC.
11.5 Tecan Group
12 Companies to Watch for
12.1 Biolife Solutions
12.2 VWR Corporation
12.3 PHC Holdings Corporation
12.4 Bluechiip Limited
12.5 Merck KGAA
12.6 Eppendorf AG
For more information about this report visit https://www.researchandmarkets.com/research/v5v48r/global_tissue?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190320005270/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Blood Banking
KEYWORD: EUROPE ASIA PACIFIC NORTH AMERICA
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 03/20/2019 05:38 AM/DISC: 03/20/2019 05:38 AM